Ocular Therapeutix (OCUL) Change in Receivables (2013 - 2026)
Ocular Therapeutix's Change in Receivables came in at $5.91 million for Q2 2026, up 13.9% from $5.19 million a year earlier.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Change in Receivables (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ocular Therapeutix reported Change in Receivables of -$151,000; for FY2025, it was -$1.74 million.
- Going back by year, Change in Receivables was $6.21 million in FY2024 (+27.9%), $4.85 million in FY2023, $190,000 in FY2022 (-97.9%) and $8.88 million in FY2021 (-8.5%).
- The Q2 2026 figure represents the highest quarterly Change in Receivables since Q2 2023.
- The fastest year-over-year change in Change in Receivables over five years came in Q4 2023 (growth of 70.1%), and the weakest in Q3 2021 (a decline of 83.3%).
- Business Quant data shows OCUL's Change in Receivables at -$6.3 million (Q1 2026), -$118,000 (Q4 2025) and $356,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Ocular Therapeutix | 1.45 Bn | -895.10 Mn | 11.46 Mn | 5.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.91 Mn |
| Mar 31, 2026 | -6.30 Mn |
| Dec 31, 2025 | -118,000.00 |
| Sep 30, 2025 | 356,000.00 |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | -7.17 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 367,000.00 |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | -3.72 Mn |
| Jun 30, 2023 | 6.19 Mn |
| Mar 31, 2023 | -201,000.00 |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | -680,000.00 |
| Jun 30, 2022 | -2.73 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 818,000.00 |
API Access
Ocular Therapeutix Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();